Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention

Details for Australian Patent Application No. 2004212305 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hilbrich, Lutz; Humphreys, David Michael; Gilbert, James C.; Riedel, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2004212305

PCT Pub. Number WO2004/071385

Priority 103 06 179.7 13.02.03 DE; 03018212.5 08.08.03 EP

Filing date 10 February 2004

Wipo publication date 26 August 2004

International Classifications

A61K 031/60 - Salicylic acid

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/071385 Priority application(s): WO2004/071385

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212308-Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries

2004212297-The use of lupin conglutin for the treatment of type II diabetes